IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

MEI Pharma Inc

CUSIP: 55279B902 | 6 institutional holders

Quarters

Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile